Machine‐learning‐based approach for predicting response to anti‐calcitonin gene‐related peptide ( CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study

A decision support system for primary headache developed through machine learning

(2022) Fangfang Liu et al.   PeerJ

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

(2021) Fabrizio Vernieri et al.   JOURNAL OF HEADACHE AND PAIN

The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study

(2021) Marta Torres-Ferrús et al.   JOURNAL OF NEUROLOGY

MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

(2021) Robert Belvís et al.   JOURNAL OF HEADACHE AND PAIN

Predictors of response to erenumab after 12 months of treatment

(2021) Carlo Baraldi et al.   Brain and Behavior

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study

(2021) Fabrizio Vernieri et al.   EUROPEAN JOURNAL OF NEUROLOGY

Clinic and genetic predictors in response to erenumab

(2021) Chiara Zecca et al.   EUROPEAN JOURNAL OF NEUROLOGY

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

(2021) Edoardo Caronna et al.   JOURNAL OF HEADACHE AND PAIN

Hyperparameter Optimization for Transfer Learning of VGG16 for Disease Identification in Corn Leaves Using Bayesian Optimization

(2021) Malliga Subramanian et al.   Big Data

PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine

(2021) Messoud Ashina et al.   Pain Management

Cluster-Then-Classify Methodology for the Identification of Pain Episodes in Chronic Diseases

(2021) Javier Galvez-Goicurla et al.   IEEE Journal of Biomedical and Health Informatics

Are machine learning approaches the future to study patients with migraine?

(2020) Maria A. Rocca et al.   NEUROLOGY

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response

(2020) Gregor Broessner et al.   HEADACHE

Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study

(2020) Piero Barbanti et al.   HEADACHE

Machine learning in the clinical and language characterisation of primary progressive aphasia variants

(2019) Jordi A. Matias-Guiu et al.   CORTEX

Machine learning applications in epilepsy

(2019) Bardia Abbasi et al.   EPILEPSIA

The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response

(2019) Jan Lewis Brandes et al.   CEPHALALGIA

Subgrouping Factors Influencing Migraine Intensity in Women: A Semi‐automatic Methodology Based on Machine Learning and Information Geometry

(2019) Francisco J. Pérez‐Benito et al.   Pain Practice

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

(2018) Vladimir Skljarevski et al.   CEPHALALGIA

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

(2018) Cristina Tassorelli et al.   CEPHALALGIA

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

(2018) David W Dodick et al.   CEPHALALGIA

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

(2018) David W. Dodick et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Classifiers and their Metrics Quantified

(2018) J. B. Brown   Molecular Informatics

Galcanezumab in chronic migraine

(2018) Holland C. Detke et al.   NEUROLOGY

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

(2017) Stewart Tepper et al.   LANCET NEUROLOGY

Fremanezumab for the Preventive Treatment of Chronic Migraine

(2017) Stephen D. Silberstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Deep learning

(2015) Yann LeCun et al.   NATURE

Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine

(2010) Min Yang et al.   CEPHALALGIA

Prognostic prediction of therapeutic response in depression using high-field MR imaging

(2010) Qiyong Gong et al.   NEUROIMAGE

HIT-6 and MIDAS as Measures of Headache Disability in a Headache Referral Population

(2009) Khara M. Sauro et al.   HEADACHE

Headache Impact Test-6 (HIT-6) Scores for Migraine Patients: Their Relation to Disability as Measured from a Headache Diary

(2009) Hae Eun Shin et al.   Journal of Clinical Neurology